Bookmark
Forward
Explore Literature Results
QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9667723F46F28605F09734A99CA4DA2;jsessionid=6961CF836CF5728373E2183EADAB2533;jsessionid=2895DFEDBF1325C8CD2C502532774450;jsessionid=33C9460D4831AA6D3B7A709D82A8F842;jsessionid=85F15CED6463C46C050D9C5117AA6325;jsessionid=5D3C27609552C53E1723AE2BAAB2B7B7 (gene)
Most Relevant Literature
- Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
- Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
- Stability of varicella-zoster virus open reading frame 63.
- Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
- Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…
Most Relevant Clinical Trials
There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9667723F46F28605F09734A99CA4DA2;jsessionid=6961CF836CF5728373E2183EADAB2533;jsessionid=2895DFEDBF1325C8CD2C502532774450;jsessionid=33C9460D4831AA6D3B7A709D82A8F842;jsessionid=85F15CED6463C46C050D9C5117AA6325;jsessionid=5D3C27609552C53E1723AE2BAAB2B7B7
Explore Clinical Trials Results
